ROR1 and neoplasm: In previous reports, we have described the effects of two small-molecule ROR1 inhibitors (KAN0439834 and KAN0441571C) targeting the cytoplasmic tyrosine kinase domain that dephosphorylated ROR1 and induced tumor cell apoptosis [13,20,46,74].